Collegium Pharmaceutical, Inc. (COLL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.47B |
| Enterprise Value | 2.16B |
| P/E Ratio | 17.72 |
| PEG Ratio | 0.6 |
| Price/Sales Ratio | 1.09 |
| Price/Book Ratio | 2.82 |
| Enterprise/Revenue | 1.99 |
| Enterprise/EBITDA | 2.74 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.06 |
| Operating Margin | 0.2 |
| Return On Assets | 0.02 |
| Return On Equity | 0.16 |
| Revenue | 780.57M |
| Revenue/Share | 24.9 |
| Gross Profit | 463.26M |
| EBITDA | 401.01M |
| Net Income | 62.87M |
| Diluted EPS | 1.73 |
| Total Cash | 129.47M |
| Total Cash/Share | 3.99 |
| Total Debt | 857.79M |
| Total Debt/Equity | 2.75 |
| Current Ratio | 1.03 |
| Book Value Per Share | 9.61 |
| 52-Week Change | -30.68 |
| 52-Week High | 50.79 |
| 52-Week Low | 25.47 |
| Moving Average 50 Days | 33.63 |
| Moving Average 200 Days | 38.92 |
| Average Volume | 532,832 |
| Shares Outstanding | 32.43M |
| % Held by Institutions | 123.36 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |